We spearhead the communication of Grifols'IPO in 2006. Since then, we have worked in close collaboration with the company's Communication and Public Relations Department
Grifols is a global healthcare company with more than a 75-year legacy of improving people's health and well-being trought the development of protein therapies, hospital pharmacy products and diagnostic technology for clinical use.
The company is present in more than 100 countries worldwide, with headquarters located in Barcelons, Spain. Grifols is a leader in plasma collection with a network of close 180 plasma donation centers in the U.S., and is a leading producer of plasma-derived medicines. As a recognized leader in transfusion medicine, Grifols offers a comprehensive range of transfusion medicine, hemostasis, and immunuassay solutions for clinical laboratories, blood banks, and transfusion centers.
Areas of action
Communications consulting for financial operations: IPO, acquisitions (Talecris / Progenika) and debt restructuring.
Crisis prevention and management.
Management of press relations and high-profile analysts: press releases / shareholder reports / interviews / factory visits / press conferences.
Coordination of national and international media outlets.
Creation of informative collateral for different stakeholders: Q & A, key messages, etc.
Communication for new products and hospital-management systems.
Management of corporate relations for the inaugurations and expansion of Grifols' facilities.
Development of annual report.
Corporate, health care and institutional press office.
Este sitio web utiliza Cookies propias y de terceros para recopilar información con la finalidad de mejorar nuestros servicios. Si continua navegando, supone la aceptación de la instalación de las mismas.